Immuneering Corporation (IMRX)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Assets | 122.37M | 107.7M | 124.9M | 113.88M | 102.59M | 87.98M | 77.09M | 68.56M |
Total Current Assets | 108.75M | 94.23M | 111.51M | 100.58M | 89.08M | 74.45M | 63.69M | 55.26M |
Cash and Equivalents | 72.64M | 77.43M | 104.02M | 68.04M | 59.41M | 66.29M | 59.73M | 45.21M |
Total Non-Current Assets | 14.99M | 14.79M | 14.75M | 14.69M | 14.9M | 14.88M | 14.69M | 14.5M |
Total Liabilities | 12.52M | 9.91M | 9.79M | 9.86M | 12.01M | 9.26M | 10.78M | 10.84M |
Total Current Liabilities | 8.05M | 5.53M | 5.48M | 5.62M | 7.85M | 5.18M | 6.78M | 6.92M |
Total Non-Current Liabilities | 4.46M | 4.38M | 4.31M | 4.24M | 4.16M | 4.08M | 4M | 3.92M |
Common Equity | 26k | 26k | 29k | 29k | 29k | 30k | 30k | 31k |
Retained Earnings | -109.79M | -123.39M | -135.58M | -148.18M | -163.26M | -177.57M | -191.65M | -206.24M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 14.1M | 38.42M | 166.71M | 122.37M | 102.59M |
Total Current Assets | 14.06M | 37.73M | 152.33M | 108.75M | 89.08M |
Cash and Equivalents | 13.78M | 37.09M | 74.89M | 72.64M | 59.41M |
Total Non-Current Assets | -6.53M | -22.48M | 155.98M | 109.85M | 90.58M |
Total Liabilities | 4.02M | 2.8M | 10.73M | 12.52M | 12.01M |
Total Current Liabilities | 505k | 2.26M | 5.63M | 8.05M | 7.85M |
Total Non-Current Liabilities | 3.51M | 544k | 5.09M | 4.46M | 4.16M |
Total Equity | -6.53M | -22.48M | 155.98M | 109.85M | 90.58M |
Common Equity | 5k | 5k | 26k | 26k | 29k |
Retained Earnings | -8.7M | -25.74M | -59.27M | -109.79M | -163.26M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.